Digitisation | August 08, 2025
ekincare launches elva.AI to resolve 80% of employee healthcare queries
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
Athena is also exploring the use of this technology for expanded carrier screening
The operating profit (EBITDA) rose 20.7% to Rs. 156.4 crore
The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
Subscribe To Our Newsletter & Stay Updated
